Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.

Mbunwe E, Van der Auwera BJ, Weets I, Van Crombrugge P, Crenier L, Coeckelberghs M, Seret N, Decochez K, Vandemeulebroucke E, Gillard P, Keymeulen B, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2013 Sep;56(9):1964-70. doi: 10.1007/s00125-013-2951-8. Epub 2013 May 28.

PMID:
23712485
[PubMed - indexed for MEDLINE]
2.

[How I explore ... a risk difference in the occurrence of an event in clinical trials].

Scheen AJ, Ernest P, Jandrain B.

Rev Med Liege. 2012 Nov;67(11):597-602. Review. French.

PMID:
23346831
[PubMed - indexed for MEDLINE]
3.

HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Mbunwe E, Van der Auwera BJ, Vermeulen I, Demeester S, Van Dalem A, Balti EV, Van Aken S, Derdelinckx L, Dorchy H, De Schepper J, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers D, Weets I, Gorus FK; Belgian Diabetes Registry.

Diabetes. 2013 Apr;62(4):1345-50. doi: 10.2337/db12-0747. Epub 2012 Nov 16.

PMID:
23160529
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Renal SGLT2 inhibitors, new agents for the management of type 2 diabetes].

Scheen AJ, Radermecker RP, Ernest P, Jandrain BJ.

Rev Med Suisse. 2011 Aug 31;7(306):1621-4, 1626-9. French.

PMID:
21972728
[PubMed - indexed for MEDLINE]
5.

[Strategies avoiding inertia and non compliance in clinical trials].

Jandrain BJ, Ernest P, Radermecker RP, Scheen AJ.

Rev Med Liege. 2010 May-Jun;65(5-6):246-9. French.

PMID:
20684401
[PubMed - indexed for MEDLINE]
6.

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Vandemeulebroucke E, Keymeulen B, Decochez K, Weets I, De Block C, Féry F, Van de Velde U, Vermeulen I, De Pauw P, Mathieu C, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2010 Jan;53(1):36-44. doi: 10.1007/s00125-009-1569-3. Epub 2009 Nov 7.

PMID:
19898832
[PubMed - indexed for MEDLINE]
7.

[Optimisation of pharmacological therapy in a patient with a newly diagnosed type 2 diabetes].

De Flines J, Radermecker RP, Jandrain BJ, Scheen AJ.

Rev Med Liege. 2009 Feb;64(2):109-14. French.

PMID:
19370857
[PubMed - indexed for MEDLINE]
8.

[Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials].

Radermecker RP, Philips JC, Jandrain B, Paquot N, Scheen AJ.

Rev Med Liege. 2008 Jul-Aug;63(7-8):511-8. French.

PMID:
18771232
[PubMed - indexed for MEDLINE]
9.

[Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia].

Radermecker RR, Philips JC, Jandrain BJ, Paquot N, Lefèbvre PJ, Scheen AJ.

Rev Med Liege. 2008 May-Jun;63(5-6):280-6. French.

PMID:
18669193
[PubMed - indexed for MEDLINE]
10.

[Alcohol, insulin sensitivity and diabetes].

Magis DC, Jandrain BJ, Scheen AJ.

Rev Med Liege. 2003 Jul-Aug;58(7-8):501-7. Review. French.

PMID:
14579614
[PubMed - indexed for MEDLINE]
11.

[Prevention of hypoglycemia in patients with type 1 diabetes].

Radermecker RP, Jandrain B, Paquot N, Philips JC, Contessi E, Lavigne M, Rinaldi AM, Scheen AJ.

Rev Med Liege. 2003 Jun;58(6):361-8. Review. French.

PMID:
12945232
[PubMed - indexed for MEDLINE]
12.

[Postprandial hyperglycemia. II. Pharmacological approaches].

Scheen AJ, Letiexhe MR, Geronooz I, Paquot N, Jandrain B.

Rev Med Liege. 2002 Apr;57(4):196-201. Review. French.

PMID:
12073790
[PubMed - indexed for MEDLINE]
13.

[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management].

Scheen AJ, Paquot N, Jandrain B, Lefèbvre PJ.

Rev Med Liege. 2002 Mar;57(3):138-41. Review. French.

PMID:
12014260
[PubMed - indexed for MEDLINE]
14.

[How I explore ... the risk of a patient developing type 2 diabetes].

Scheen AJ, Paquot N, Jandrain B.

Rev Med Liege. 2002 Feb;57(2):113-5. Review. French.

PMID:
11942176
[PubMed - indexed for MEDLINE]
15.

[How I explore ... the different forms of sugar diabetes: clinical and biological differental diagnosis].

Scheen AJ, Philips JC, Luyckx FH, Paquot N, Jandrain B.

Rev Med Liege. 2001 Sep;56(9):650-5. French.

PMID:
11702508
[PubMed - indexed for MEDLINE]
16.

[Multidisciplinary management of the obese patient: example from the Obesity Center at the University of Liege].

Scheen AJ, Rorive M, Letiexhe M, Devoitille L, Jandrain B.

Rev Med Liege. 2001 Jul;56(7):474-9. French.

PMID:
11523296
[PubMed - indexed for MEDLINE]
17.

[Muscular exercise in the diabetic patient].

Jandrain BJ, Scheen AJ.

Rev Med Liege. 2001 May;56(5):300-5. French.

PMID:
11475924
[PubMed - indexed for MEDLINE]
18.

[Hormonal-metabolic adaptations to muscular exercise].

Scheen AJ, Jandrain BJ.

Rev Med Liege. 2001 Apr;56(4):195-9. Review. French.

PMID:
11421151
[PubMed - indexed for MEDLINE]
19.

[Treatment of obesity: are drug combinations effective?].

Jandrain B.

J Pharm Belg. 1996 Jul-Aug;51(4):228-30. French. No abstract available.

PMID:
8965256
[PubMed - indexed for MEDLINE]
20.

Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity.

Castillo MJ, Scheen AJ, Jandrain B, Lefèbvre PJ.

Int J Obes Relat Metab Disord. 1994 Jan;18(1):47-53.

PMID:
8130815
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk